Cargando…
Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
BACKGROUND: Inhaled therapies are key components of asthma and chronic obstructive pulmonary disease (COPD) treatments. Although the use of pressurised metered-dose inhalers (pMDIs) accounts for <0.1% of global greenhouse gas emissions, their contribution to global warming has been debated and ef...
Autores principales: | Pernigotti, Daniele, Stonham, Carol, Panigone, Sara, Sandri, Federica, Ferri, Rossella, Unal, Yasemin, Roche, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650484/ https://www.ncbi.nlm.nih.gov/pubmed/34872967 http://dx.doi.org/10.1136/bmjresp-2021-001071 |
Ejemplares similares
-
Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
por: Panigone, Sara, et al.
Publicado: (2020) -
Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
por: Woodcock, Ashley, et al.
Publicado: (2022) -
Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
por: Delaney, Stephen, et al.
Publicado: (2016) -
What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective
por: Howard, Sam, et al.
Publicado: (2016) -
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
por: Patel, Roshni, et al.
Publicado: (2020)